Skip to main content
. 2017 Jun 27;8(40):67439–67456. doi: 10.18632/oncotarget.18698

Figure 3. Change in PEBP1 expression correlates with survival after vaccination.

Figure 3

(A-D) Expression of PEBP1 was assessed in Copenhagen patients prior to or after 4 or 6 rounds of vaccination. (A) Spearman correlation of PEBP1 at the 3 time-points (p-value one-tailed). Respectively n=39, n=38 and n=30 pre-, after 4 and after 6 vaccinations. (B) Expression of PEBP1 at each time-point in short (<14 months) or long survivors (> 14 months). Ns= non-significant * p<0.05 ** p<0.01 by t-test (one-tailed). (C) Course of PEBP1 expression during successive rounds of vaccination in short and long survivors (Mean +/− SEM). (D) Spearman correlation of survival time with the change in PEBP1 expression with respect to the start of vaccination (p-value one-tailed). E Change in PEBP1 expression in relation to survival in patient samples from Innsbruck (n=7 stage IV in black; n=2 stage III in red).